Johan Wedell-Wedellsborg, Director at Y-mAbs Therapeutics, Inc. (YMAB), sold 69,014 shares at $34.03 ($2.3M) on 2021-06-04, disclosed to the SEC on 2021-06-07.
Open-market sale of $2.3M YMAB by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.19 | 30,666 | $1.0M | 44.3% |
| 2 | $33.19 | 30,666 | $1.0M | 44.3% |
| 3 | $34.03 | 3,841 | $131K | 5.7% |
| 4 | $34.03 | 3,841 | $131K | 5.7% |
| Total | $33.28 avg | 69,014 | $2.3M | 100% |
| Filing → |
| YMAB | BUY | 2023-12-01 | $619K | — | Filing → |
| YMAB | BUY | 2023-11-29 | $1.0M | — | Filing → |
| YMAB | BUY | 2023-05-17 | $982K | — | Filing → |